Skip to main content

Peer Review reports

From: Combining therapy with recombinant human endostatin and cytotoxic agents for recurrent disseminated glioblastoma: a retrospective study

Original Submission
24 Jun 2019 Submitted Original manuscript
11 Aug 2019 Reviewed Reviewer Report - Shigeru Yamaguchi
10 Sep 2019 Reviewed Reviewer Report - John McGregor
25 Nov 2019 Author responded Author comments - Jing-jing Ge
Resubmission - Version 2
25 Nov 2019 Submitted Manuscript version 2
1 Dec 2019 Reviewed Reviewer Report - Shigeru Yamaguchi
7 Dec 2019 Reviewed Reviewer Report - Kenji Hirata
11 Dec 2019 Author responded Author comments - Jing-jing Ge
Resubmission - Version 3
11 Dec 2019 Submitted Manuscript version 3
Publishing
15 Dec 2019 Editorially accepted
8 Jan 2020 Article published 10.1186/s12885-019-6467-6

You can find further information about peer review here.

Back to article page